These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 11156420)

  • 1. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microcell hybrid-based "elimination test" identifies a 1-Mb putative tumor-suppressor region at 3p22.2-p22.1 centromeric to the homozygous deletion region detected in lung cancer.
    Kholodnyuk ID; Kost-Alimova M; Yang Y; Kiss H; Fedorova L; Klein G; Imreh S
    Genes Chromosomes Cancer; 2002 Jul; 34(3):341-4. PubMed ID: 12007195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3p21.3 region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumor growth in SCID mice.
    Kholodnyuk I; Kost-Alimova M; Kashuba V; Gizatulin R; Szeles A; Stanbridge EJ; Zabarovsky ER; Klein G; Imreh S
    Genes Chromosomes Cancer; 1997 Mar; 18(3):200-11. PubMed ID: 9071573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth.
    Imreh S; Kost-Alimova M; Kholodnyuk I; Yang Y; Szeles A; Kiss H; Liu Y; Foster K; Zabarovsky E; Stanbridge E; Klein G
    Genes Chromosomes Cancer; 1997 Nov; 20(3):224-33. PubMed ID: 9365829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM.
    Szeles A; Yang Y; Sandlund AM; Kholodnyuk I; Kiss H; Kost-Alimova M; Zabarovsky ER; Stanbridge E; Klein G; Imreh S
    Genes Chromosomes Cancer; 1997 Dec; 20(4):329-36. PubMed ID: 9408748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1-Mb PAC contig spanning the common eliminated region 1 (CER1) in microcell hybrid-derived SCID tumors.
    Yang Y; Kiss H; Kost-Alimova M; Kedra D; Fransson I; Seroussi E; Li J; Szeles A; Kholodnyuk I; Imreh MP; Fodor K; Hadlaczky G; Klein G; Dumanski JP; Imreh S
    Genomics; 1999 Dec; 62(2):147-55. PubMed ID: 10610706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
    Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice.
    Kholodnyuk ID; Kozireva S; Kost-Alimova M; Kashuba V; Klein G; Imreh S
    Int J Cancer; 2006 Jul; 119(1):99-107. PubMed ID: 16432833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.
    Yang Y; Kost-Alimova M; Ingvarsson S; Qianhui Q; Kiss H; Szeles A; Kholodnyuk I; Cuthbert A; Klein G; Imreh S
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1136-41. PubMed ID: 11158607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
    Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ
    Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
    Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.
    Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P
    Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of FHIT expression in gastric carcinoma.
    Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
    Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
    Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B
    Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
    Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
    Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.
    Glover TW; Hoge AW; Miller DE; Ascara-Wilke JE; Adam AN; Dagenais SL; Wilke CM; Dierick HA; Beer DG
    Cancer Res; 1998 Aug; 58(15):3409-14. PubMed ID: 9699673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.